Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Chen, Y., Krishan, M., Nebert, D
Drugs Context
Liposomal encapsulation of eremantholide C and goyazensolide in a sesquiterpene formulation mitigates toxicity while maintaining anti-hyperuricemic efficacy through enhanced encapsulation and sustained release, with preclinical evaluation confirming serum uric acid stabilization, excellent biocompatibility, and therapeutic potential for concurrent hyperuricemia/gout management, warranting translational investigation ( Biomimetic nanoliposomes represent a cutting-edge subset of LBDDSs
Snchez MB, Callaghan MJ, Selfe J, Twigg M, Smith T
US$ 28.71
US$ 23.84
US$ 20.09
US$ 23.70
US$ 20.83
US$ 23.32
US$ 26.53
US$ 24.06
US$ 23.59
US$ 28.46
US$ 27.65
US$ 29.44
